학술논문

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
Document Type
Article
Source
In Annals of Oncology February 2019 30(2):259-265
Subject
Language
ISSN
0923-7534